Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neridronic Acid in CRPS-I
NCT02402530Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2015
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of neridronic acid in complex regional pain syndrome type I (CRPS), sponsored by Grünenthal GmbH. Started Apr 2015; status: completed.
02
Drugs
neridronic acid
03
Conditions
complex regional pain syndrome type I (CRPS)
Beyond the preview
Go deeper on NCT02402530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402530.